CS
MRVI icon

Candriam SCA’s Maravai LifeSciences MRVI Stock Holding History

Candriam SCA’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$147K Buy
+23,595
New +$102K ﹤0.01% 675
2023
Q3 		– Sell
-100,000
Closed -$1.24M – 681
2023
Q2 		$1.24M Hold
100,000
– – 0.01% 575
2023
Q1 		$1.29M Sell
100,000
-30,000
-23% -$431K 0.01% 663
2022
Q4 		$1.86M Buy
+130,000
New +$2.05M 0.01% 594

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Candriam SCA's MRVI Position: Q2 2026 in Review

Candriam SCA opened a new position in Maravai LifeSciences (MRVI) in Q2 2026: 23,595 shares worth $147K. The stake represents ﹤0.01% of the portfolio and ranks #675 among its holdings. This is a return to the name: Candriam SCA previously reported a position in MRVI as recently as Q2 2023.

Candriam SCA first reported a position in MRVI in Q4 2022 and has held it in 4 quarters since. The position peaked at $1.86M in Q4 2022. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Candriam SCA held 23,595 shares of Maravai LifeSciences worth $147K as of Q2 2026.
  • Maravai LifeSciences was a new Candriam SCA position in Q2 2026.
  • Maravai LifeSciences made up ﹤0.01% of Candriam SCA's portfolio in Q2 2026, its #675 holding.
  • Candriam SCA first reported a position in Maravai LifeSciences in Q4 2022 and has held it in 4 quarters since.
  • Candriam SCA's Maravai LifeSciences position peaked at $1.86M in Q4 2022.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.